EPHA2 and cancer: EphA2 non-canonical signaling is often elevated in cancer cells and promotes their oncogenic properties, including epithelial-mesenchymal transition, invasiveness and metastasis, mechanotransduction, stem cell-like properties, and drug resistance2,3,22–25.